Source: Eur Respir J 2016; 47: 177-185
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Gernez Yael, Walters Jeffrey, Mirkovic Bojana, Lavelle Gillian M., Colleen Dunn E., Davies Zoe A., Everson Cassie, Tirouvanziam Rabindra, Silver Elana, Wallenstein Sylvan, Chotirmall Sanjay H., McElvaney Noel G., Herzenberg Leonore A., Moss Richard B.. Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis. Eur Respir J 2016; 47: 177-185

Member's Comments

No comment yet.

Related content which might interest you: Bronchodilator responsiveness in children with cystic fibrosis and allergic bronchopulmonary aspergillosis Source: Eur Respir J, 56 (2) 2000175; 10.1183/13993003.00175-2020 Year: 2020 Allergic bronchopulmonary aspergillosis in cystic fibrosis Source: Eur Respir J 2001; 17: 156 Year: 2001 Allergic bronchopulmonary aspergillosis in cystic fibrosis Source: Eur Respir J 2001; 17: 1052-1053 Year: 2001 Allergic bronchopulmonary aspergillosis in cystic fibrosis Source: Annual Congress 2009 - Update on eosinophilic lung diseases Year: 2009 Changes in total IgE levels predict pulmonary outcome in cystic fibrosis related allergic bronchopulmonary aspergillosis Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis Source: Eur Respir J 2008; 31: 36-42 Year: 2008 Long term follow up of the lung function in cystic fibrosis patients with allergic bronchopulmonary aspergillosis (ABPA) Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Vitamin D level in cystic fibrosis patients with allergic bronchopulmonary aspergillosis and aspergillus sensitization Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Surfactant protein D in serum from patients with allergic bronchopulmonary aspergillosis Source: Eur Respir J 2003 Oct 01;22(4):592-595 Year: 2003 Risk factors for allergic bronchopulmonary aspergillosis in paediatric patients with cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Association of pulmonary aspergilloma and allergic bronchopulmonary aspergillosis Source: Eur Respir Rev 2010 19: 349-351 Year: 2010 Airway remodelling easily develops in patients with allergic bronchopulmonary aspergillosis Source: Annual Congress 2009 - Airways remodelling Year: 2009 Allergic bronchopulmonary aspergillosis - therapeutical role of bronchoalveolar lavage Source: Eur Respir J 2005; 26: Suppl. 49, 504s Year: 2005 Steroid sparing effect of anti-IgE antibody in allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 The efficacity of omaluzimab in a case series with allergic bronchopulmonary aspergillosis and cystic fibrosis Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015 Effects and side effects of long term steroid therapy of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Concurrent allergic bronchopulmonary aspergillosis and aspergilloma: is it a more severe form of the disease? Source: Eur Respir Rev 2010 19: 261-263 Year: 2010 Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis Source: Eur Respir J 2014; 43: 1487-1500 Year: 2014 Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis Source: Eur Respir J 2003; 21: 582-588 Year: 2003 Regular prophylactic bronchoscopy and lavage for lobar collapse in patients with allergic bronchopulmonary aspergillosis Source: Annual Congress 2010 - The broad spectrum of bronchoscopy Year: 2010